The Central Virus Core (CVC) will play a pivotal role in the Birmingham CFAR. The CVC will provide a centralized, fully- equipped, and highly supervised Biosafety Level 3 (BSL 3) laboratory facility for all infectious HIV work by center members and will further serve as a Center resource for the maintenance and storage of thoroughly characterized stocks of HIV virus isolates, infected cell lines, and virus-specific monoclonal and polyclonal antibodies. Although all recombinant HIV plasmid and phage constructs will be catalogued, propagated, and provided to CFAR members through the Molecular Biology Core, the CVC will play an important role in the initial construction of these recombinant HIV containing vectors which are often derived initially from primary or passaged cultures of HIV virus. The CVC directors (Drs. Shaw and Hahn) have demonstrated the successful application of the concept of a CVC for provision of virus-specific reagents by their current ongoing contract with the National Institutes of Allergy and Infectious Diseases for the provision of HIV proviral clones, growing stocks, and relevant genetic information for the NIAID AIDS Reagent Program (Appendix). The six programmatic areas comprising the CFAR Basic Sciences Program and the three programmatic areas comprising the Clinical Sciences Program will maximally utilize the CVC as the primary site for all infectious HIV work, as a source for HIV related reagents, and as a resource for information and experimental design and development relevant to their programmatic areas. Thirty-three NIH funded CFAR members have been identified who will utilize the CVC services. The CVC facility will be centrally located to these investigators and will consist of a 2,000 sq.ft. containment facility having six individual culture rooms, a common shared equipment area containing centrifuges, automated cell counter, microscopes, freezers, and all other equipment required for virus culture and analysis. The CVC will be operated on an at-cost reimbursement basis from the research funds of its users. The CVC will limit potential exposure to infectious HIV to a single tightly controlled laboratory facility providing maximal safety and efficiency, obviate duplication of equipment, and make available to all CFAR members full facilities for HIV research and a complete spectrum of fully characterized, high quality HIV related reagents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027767-03
Application #
3810412
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Adeli, Ehsan; Kwon, Dongjin; Zhao, Qingyu et al. (2018) Chained regularization for identifying brain patterns specific to HIV infection. Neuroimage 183:425-437
Verma, Richa; Sahu, Rajnish; Dixit, Saurabh et al. (2018) The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic Front Immunol 9:2369
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Crockett, Kaylee B; Turan, Bulent (2018) Moment-to-moment changes in perceived social support and pain for men living with HIV: an experience sampling study. Pain 159:2503-2511
Carson, Tiffany L; Wang, Fuchenchu; Cui, Xiangqin et al. (2018) Associations Between Race, Perceived Psychological Stress, and the Gut Microbiota in a Sample of Generally Healthy Black and White Women: A Pilot Study on the Role of Race and Perceived Psychological Stress. Psychosom Med 80:640-648
Salantes, D Brenda; Zheng, Yu; Mampe, Felicity et al. (2018) HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. J Clin Invest 128:3102-3115
Goodin, Burel R; Owens, Michael A; White, Dyan M et al. (2018) Intersectional health-related stigma in persons living with HIV and chronic pain: implications for depressive symptoms. AIDS Care 30:66-73
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Bilal, Usama; McCaul, Mary E; Crane, Heidi M et al. (2018) Predictors of Longitudinal Trajectories of Alcohol Consumption in People with HIV. Alcohol Clin Exp Res 42:561-570
Bekhbat, Mandakh; Mehta, C Christina; Kelly, Sean D et al. (2018) HIV and symptoms of depression are independently associated with impaired glucocorticoid signaling. Psychoneuroendocrinology 96:118-125

Showing the most recent 10 out of 955 publications